BioVex is a biotechnology company focused on the development and commercialization of biological treatments for cancer and the prevention of infectious disease.   34 Commerce Way
Woburn MA 01801
United States
T. +1 781 376 4900
F. +1 781 933 6025
www.biovex.com
Cardoz develops medical therapies for inflammatory cardiovascular diseases. The lead program for prevention of growth and rupture of abdominal aortic aneurysm is in phase II clinical development.  

Cardoz AB
Box 2077
SE-103 12 Stockholm
Sweden
P. +46 856 630 173
F. +46 856 630 014

Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on a cell therapy.  

Calle Marconi, 1
Parque tecnológico de Madrid
28760 Tres Cantos
Madrid, Spain
P.+34 918 049 264
F. +34 918 049 263
www.cellerix.com

Endosense is a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias.  

Chemin du Grand-Puits 42
1217 Meyrin
Geneva, Switzerland
P. +41 223 061 960
F. +41 223 061 9 79
www.endosense.com

 
 Ysios Capital Partners | Contact | Español | Design by amc | Ysios © 2008